Biomedical Engineering Reference
In-Depth Information
54. Lee JP, Jeyakumar M, Gonzalez R, Takahashi H, Lee PJ, Baek RC, Clark D, Rose H, Fu G,
Clarke J, McKercher S, Meerloo J, Muller FJ, Park KI, Butters TD, Dwek RA, Schwartz P,
Tong G, Wenger D, Lipton SA, Seyfried TN, Platt FM, Snyder EY (2007) Stem cells act
through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.
Nat Med 13:439-447
55. Windrem MS, Schanz SJ, Guo M, Tian GF, Washco V, Stanwood N, Rasband M, Roy NS,
Nedergaard M, Havton LA, Wang S, Goldman SA (2008) Neonatal chimerization with
human glial progenitor cells can both remyelinate and rescue the otherwise lethally
hypomyelinated shiverer mouse. Cell Stem Cell 2:553-565
56. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U,
Ourednik V, Black PM, Breakefield XO, Sndyer EY (2000) Neural stem cells display
extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc
Natl Acad Sci USA 97:12846-12851
57. Glass R, Synowitz M, Kronenberg G, Walzlein JH, Markovic DS, Wang LP, Gast D, Kiwit J,
Kempermann G, Kettenmann H (2005) Glioblastoma-induced attraction of endogenous neural
precursor cells is associated with improved survival. J Neurosci 25:2637-2646
58. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL,
Walsh CA, Snyder EY, Khoury SJ (2004) Directed migration of neural stem cells to sites of
CNS injury by the stromal cell-derived factor1alpha/CXC chemokine receptor 4 pathway.
Proc Natl Acad Sci USA 101:18117-18122
59. Tamaki SJ, Jacobs Y, Dohse M, Capela A, Cooper JD, Reitsma M, He D, Tushinski R,
Belichenko PV, Salehi A, Mobley W, Gage FH, Huhn S, Tsukamoto AS, Weissman IL,
Uchida N (2009) Neuroprotection of host cells by human central nervous system stem cells
in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell 5:310-319
60. Jandial R, Singec I, Ames CP, Snyder EY (2008) Genetic modification of neural stem cells.
Mol Ther 16:450-457
61. Aboody K, Capela A, Niazi N, Stern JH, Temple S (2011) Translating stem cell studies to
the clinic for CNS repair: current state of the art and the need for a Rosetta Stone. Neuron
70:597-613
62. Nikkhah G, Falkenstein G, Rosenthal C (2001) Restorative plasticity of dopamine neuronal
transplants depends on the degree of hemispheric dominance. J Neurosci 21:6252-6263
63. Alterman RL, Tagliati M, Olanow CW (2011) Open-label surgical trials for Parkinson
disease: time for reconsideration. Ann Neurol 70:5-8
64. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA (2006) Functional
engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with
telomerase-immortalized midbrain astrocytes. Nat Med 12:1259-1268
65. Lane EL, Björklund A, Dunnett SB, Winkler C (2010) Neural grafting in Parkinson's
disease unraveling the mechanisms underlying graft-induced dyskinesia. Prog Brain Res
184:295-309
66. Barker RA, Kuan WL (2010) Graft-induced dyskinesias in Parkinson's disease: what is it all
about? Cell Stem Cell 7:148-149
67. Lindvall O, Björklund A (2011) Cell therapeutics in Parkinson's disease. Neurotherapeutics
8:539-548
68. Steiner B, Winter C, Blumensath S, Paul G, Harnack D, Nikkhah G, Kupsch A (2008)
Survival and functional recovery of transplanted human dopaminergic neurons into
hemiparkinsonian rats depend on the cannula size of the implantation instrument. J Neurosci
Methods 169:128-134
69. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying
inflammation in neurodegeneration. Cell 140:918-934
70. Hansen C, Angot E, Bergström AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R,
Kallunki P, Fog K, Li JY, Brundin P (2011) a-Synuclein propagates from mouse brain to
grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest
121:715-725
